ALV Stock Analysis: Allianz SE VNA O.N. | XETRA
Insurance - Diversified | XETRA, Germany | Market Cap: 157.859m EUR | 12M Return: 16.5% | DE0008404005 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 211M
EPS Trend: 98.8%
Qual. Beats: 0
Rev. Trend: 77.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Allianz SE is a Germany-based global financial services group operating through three core segments: Property-Casualty insurance, Life/Health insurance, and Asset Management. The Property-Casualty unit offers motor liability, accident, fire, general liability, credit, and travel products to both private and corporate clients, while the Life/Health segment sells annuities, term and endowment policies, unit-linked products, and health and long-term care coverage on individual and group bases. The Asset Management division serves third-party institutional and retail investors with equity, fixed income, multi-asset, and alternative products spanning real estate, infrastructure, and real assets. The company also provides retail banking and digital investment services, and is headquartered in Munich.
Founded in 1890, Allianz is one of the longest-established large insurance groups in Europe, and its three-pillar structure - underwriting, life/health, and asset management - reflects a common diversification model used by major multi-line insurers to balance volatile insurance underwriting results with the more stable, fee-based revenues of asset management. The combination of insurance distribution with in-house asset management is a characteristic feature of European composite insurers, allowing premium income to be recycled internally into investment portfolios managed for both policyholders and external clients.
- P&C combined ratio improvement drives underwriting margin expansion
- PIMCO and AllianzGI fee revenue pressured by market corrections
- Solvency II capital position supports sustained share buybacks
| Net Income: 11.8b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.11 > 1.0 |
| NWC/Revenue: -140.7% < 20% (prev -141.1%; Δ 0.46% < -1%) |
| CFO/TA 0.03 > 3% & CFO 33.2b > Net Income 11.8b |
| Net Debt (-582b) to EBITDA (17.6b): -33.09 < 3 |
| Current Ratio: 0.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (382.2m) vs 12m ago -0.99% < -2% |
| Gross Margin: 85.11% > 18% (prev 82.54%; Δ 2.58% > 0.5%) |
| Asset Turnover: 15.45% > 50% (prev 13.23%; Δ 2.23% > 0%) |
| Interest Coverage Ratio: 22.84 > 6 (EBIT TTM 17.3b / Interest Expense TTM 758.0m) |
| A: -0.21 (Total Current Assets 633b - Total Current Liabilities 857b) / Total Assets 1073b |
| B: 0.03 (Retained Earnings 36.0b / Total Assets 1073b) |
| C: 0.02 (EBIT TTM 17.3b / Avg Total Assets 1033b) |
| D: 0.06 (Book Value of Equity 62.9b / Total Liabilities 1007b) |
| Altman-Z'' = -1.09 = CCC |
| DSRI: 1.14 (Receivables 13.7b/9.89b, Revenue 160b/131b) |
| GMI: 0.97 (GM 82.54% / 85.11%) |
| AQI: 1.06 (AQ_t 0.40 / AQ_t-1 0.38) |
| SGI: 1.22 (Revenue 160b / 131b) |
| TATA: -0.02 (NI 11.8b - CFO 33.2b) / TA 1073b) |
| Beneish M = -2.75 (Cap -4..+1) = A |
As of October 10, 2026, the stock is trading at EUR 413.40 with a total of 382,129 shares traded. Over the past week, the price has changed by +0.34%, over one month by -7.18%, over three months by -1.22% and over the past year by +16.52%.
Current recommended Stop Loss: 403.30 (which is 2.4% or 1.5 ATR below the current price).
Allianz SE VNA O.N. has no consensus analysts rating.
P/E Trailing = 13.7443
P/E Forward = 12.9199
P/S = 1.0346
P/B = 2.5955
P/EG = 2.9361
Revenue TTM = 160b EUR
EBIT TTM = 17.3b EUR
EBITDA TTM = 17.6b EUR
Long Term Debt = 31.3b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.00b EUR (from shortTermDebt, last fiscal year)
Debt = 36.1b EUR (from shortLongTermDebtTotal, last quarter) + Leases 2.39b
Net Debt = -582b EUR (calculated: Debt 36.1b - CCE 618b)
Enterprise Value = 158b EUR (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 22.84 (Ebit TTM 17.3b / Interest Expense TTM 758.0m)
EV/FCF = 5.01x (Enterprise Value 158b / FCF TTM 31.5b)
FCF Yield = 19.96% (FCF TTM 31.5b / Enterprise Value 158b)
FCF Margin = 19.74% (FCF TTM 31.5b / Revenue TTM 160b)
Net Margin = 7.39% (Net Income TTM 11.8b / Revenue TTM 160b)
Gross Margin = 85.11% ((Revenue TTM 160b - Cost of Revenue TTM 23.8b) / Revenue TTM)
Gross Margin QoQ = 90.66% (prev 79.87%)
Tobins Q-Ratio = 0.15 (Enterprise Value 158b / Total Assets 1073b)
Interest Expense / Debt = 2.10% (Interest Expense 758.0m / Debt 36.1b)
Taxrate = 25.66% (4.30b / 16.8b)
NOPAT = 12.9b (EBIT 17.3b * (1 - 25.66%))
Current Ratio = 0.74 (Total Current Assets 633b / Total Current Liabilities 857b)
Debt / Equity = 0.57 (Debt 36.1b / totalStockholderEquity, last quarter 62.9b)
Debt / EBITDA = -33.09 (Net Debt -582b / EBITDA 17.6b)
Debt / FCF = -18.46 (Net Debt -582b / FCF TTM 31.5b)
Total Stockholder Equity = 62.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.14% (Net Income 11.8b / Total Assets 1073b)
RoE = 18.75% (Net Income TTM 11.8b / Total Stockholder Equity 62.9b)
RoCE = 18.37% (EBIT 17.3b / Capital Employed (Equity 62.9b + L.T.Debt 31.3b))
RoIC = 6.11% (NOPAT 12.9b / Invested Capital 211b)
WACC = 5.22% (E(158b)/V(194b) * Re(6.06%) + D(36.1b)/V(194b) * Rd(2.10%) * (1-Tc(0.26)))
Discount Rate = 6.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.18 | Cagr: -1.08%
[DCF] Terminal Value 75.97% ; FCFF base≈31.0b ; Y1≈32.2b ; Y5≈36.5b
[DCF] Fair Price = 3.02k (EV 563b - Net Debt -582b = Equity 1145b / Shares 379.3m; r=8.35% [WACC [floored]]; 5y FCF grow 4.10% → 2.50% )
EPS Correlation: 98.75 | EPS CAGR: 14.58% | SUE: -0.50 | # QB: 0
Revenue Correlation: 76.99 | Revenue CAGR: 6.25% | SUE: 0.34 | # QB: 0
EPS current Quarter (2026-09-30): EPS=8.21 | Chg30d=-3.01% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=31.49 | Chg30d=+1.06% | Revisions=+0% | GrowthEPS=+10.1% | GrowthRev=-1.5%
EPS next Year (2027-12-31): EPS=33.36 | Chg30d=-0.49% | Revisions=+29% | GrowthEPS=+5.9% | GrowthRev=+1.9%
[Analyst] Revisions Ratio: +10% (up=4, down=3)